Tag Archives: Dr June Raine: MHRA’s Director of Vigilance and Risk Management of Medicines

Benefits of Alteplase Outweigh Risks (BBC News / MHRA)

Summary The Medicines and Healthcare Products Regulatory Agency (MHRA) review into the safety of alteplase, the thrombolytic (clot-busting) drug for the treatment of strokes, has concluded that alteplase is “safe and effective”. The expert working group of the UK’s Commission … Continue reading

Posted in Acute Hospitals, BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, Pharmacological Treatments, Stroke, UK, Universal Interest | Tagged , , , , , , , , , , , | Leave a comment